SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-051389
Filing Date
2024-12-16
Accepted
2024-12-16 16:16:03
Documents
66
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 10-Q csbr-20241031.htm   iXBRL 10-Q 800259
2 EX-31.1 csbrq21031202410-qex311.htm EX-31.1 10784
3 EX-31.2 csbrq21031202410-qex312.htm EX-31.2 10884
4 EX-32.1 csbrq21031202410-qex321.htm EX-32.1 7923
  Complete submission text file 0001628280-24-051389.txt   4980224

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20241031.xsd EX-101.SCH 36214
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT csbr-20241031_cal.xml EX-101.CAL 55207
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20241031_def.xml EX-101.DEF 126751
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20241031_lab.xml EX-101.LAB 515694
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20241031_pre.xml EX-101.PRE 331395
69 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20241031_htm.xml XML 655171
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-11504 | Film No.: 241552014
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)